Jinarc (tolvaptan)

pCPA File Number: 20857
Negotiation Status:
Negotiations were not pursued
Indication(s):
Autosomal dominant polycystic kidney disease (ADPKD)
Sponsor/Manufacturer:
Otsuka Canada Pharmaceutical Inc.
CDA-AMC Project Number:
SR0435-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: